Medical Testing

Regular exercise appears to reduce severe, long-term COVID risks, study says

Submitted by mike kraft on Wed, 2021-04-14 19:23

Regular exercise appears to reduce severe, long-term COVID risks, study says Those who keep active and work a basic amount of exercise into their day-to-day face fewer COVID risks and symptoms than those who are generally more sedentary, according to a new study examining coronavirus hospitalizations and patients’ activity levels. Jessica Schladebeck nydailynews.com

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Regular exercise appears to reduce severe, long-term COVID risks, study says
Log in or register to post comments

Discussion of 'Breakthrough' COVID Cases Among People Already Vaccinated

Submitted by mike kraft on Tue, 2021-04-13 20:27

Ginger Eatman thought she was safe after getting her second COVID-19 vaccination in February. But she kept wearing her mask, using hand sanitizer and wiping down the carts at the grocery store anyway. A few weeks later, she noticed a scratchy throat.

"By Wednesday morning, St. Patrick's Day, I was sick. I had congestion — a lot of congestion — and some coughing," says Eatman, 73, of Dallas, Ga.

Her doctor thought her symptoms might be allergies. But Eatman started feeling sicker. And then she suddenly lost her sense of smell. ...

So Eatman got tested for the coronavirus. It came back positive. ...

Eatman isn't alone in this experience. It's a long-recognized phenomenon called "vaccine breakthrough."

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Discussion of 'Breakthrough' COVID Cases Among People Already Vaccinated
Log in or register to post comments

Regeneron says antibody cocktail reduced Covid infections by 81% when given asi njection, not an IV

Submitted by mike kraft on Mon, 2021-04-12 11:31

Regeneron says its antibody cocktail injection prevents Covid In previous studies, antibodies had to be given intravenously. This one can be given with an under-the-skin injection. Matthew Herper STAT

Regeneron Pharmaceuticals said Monday that a single administration of its monoclonal antibody cocktail reduced the risk that volunteers exposed to Covid-19 would develop the disease by 81%.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Regeneron says antibody cocktail reduced Covid infections by 81% when given asi njection, not an IV
Log in or register to post comments

Efforts to detect variants step up but are still far behind,

Submitted by mike kraft on Mon, 2021-04-12 10:52

As variants surge, efforts in a patchwork of surveillance have ramped up to detect them Though variant hunting has improved, experts say it’s not enough to stay ahead of dangerous new forms of the virus. Erin Cox, Jenna Portnoy Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Efforts to detect variants step up but are still far behind,
Log in or register to post comments

How concerning are links of blood clots to AstraZeneca's vaccine?

Submitted by mike kraft on Fri, 2021-04-09 19:43

How worried should we be about links of blood clots to AstraZeneca's vaccine? Europe's drug regulator on Wednesday said it had found a possible link between AstraZeneca's COVID-19 vaccine and very rare blood clots in adults who received the shot. Britain recommended people under 30 get an alternative COVID-19 vaccine if possible. John Miller, Ludwig Burger U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about How concerning are links of blood clots to AstraZeneca's vaccine?
Log in or register to post comments

FDA "highly likely" to allow Pfizer's Covid-19 vaccine for children ages 12 to 15, official says

Submitted by mike kraft on Fri, 2021-04-09 19:11

FDA "highly likely" to allow Pfizer's Covid-19 vaccine for children ages 12 to 15, official says It’s “highly likely” the US Food and Drug Administration will allow Pfizer’s Covid-19 vaccine to be used in children aged 12 to15, according to the acting chairman of an FDA vaccine advisory committee. By <a href="/profiles/julia-hollingsworth">Julia Hollingsworth</a>, Melissa Macaya, <a href="/profiles/melissa-mahtani">Melissa Mahtani</a>, <a href="/profiles/veronica-rocha">Veronica Rocha</a> and <a href="/profiles/fernando-alfonso-iii">Fernando Alfonso III</a>, CNN

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about FDA "highly likely" to allow Pfizer's Covid-19 vaccine for children ages 12 to 15, official says
Log in or register to post comments

NIH launches study to gauge risk of allergic reactions to Pfizer, Moderna vaccines

Submitted by mike kraft on Wed, 2021-04-07 17:55

New NIH study to gauge risk of allergic reactions to Pfizer, Moderna The National Institutes of Health (NIH) announced Wednesday that it's launching a study to gauge the risk of allergic reactions to the Pfizer-BioNTech and Moderna vaccines among certain individuals. Justine Coleman TheHill

The National Institutes of Health (NIH) announced Wednesday that it's launching a study to gauge the risk of allergic reactions to the Pfizer-BioNTech and Moderna vaccines among certain individuals.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about NIH launches study to gauge risk of allergic reactions to Pfizer, Moderna vaccines
Log in or register to post comments

AstraZeneca: Researchers race to understand why handful of patients develop blot clots

Submitted by mike kraft on Wed, 2021-04-07 10:07

Europe’s vaccine divide: As scientists scramble for answers to AstraZeneca blood clot puzzle, some nations opt for caution The cases of brain clots remain very rare. That is just one challenge for researchers. Loveday Morris Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about AstraZeneca: Researchers race to understand why handful of patients develop blot clots
Log in or register to post comments

Six months later, a third of COVID-19 patients have been diagnosed psychiatric or neurological illness

Submitted by mike kraft on Wed, 2021-04-07 09:27

1 in 3 Covid-19 patients are diagnosed with a neuropsychiatric condition Six months after being diagnosed with Covid-19, 1 in 3 patients had also experienced a neuropsychiatric illness. Elizabeth Cooney STAT

Six months after being diagnosed with Covid-19, 1 in 3 patients also had experienced a psychiatric or neurological illness, mostly mood disorders but also strokes or dementia, a large new study shows.

Country / Region Tags:

General Topic Tags: